WEE1 and cancer: As a multi-kinase inhibitor, regorafenib plays its anti-tumor role by blocking the activity of multiple protein kinases that involve in cancer cell proliferation, metastasis, angiogenesis and tumor microenvironment (Teufel et al., 2019).